Current through January 8, 2025
Section 405 IAC 5-37-0.5 - DefinitionsAuthority: IC 12-15-1-10; IC 12-15-21-2; IC 12-15-21-3
Affected: IC 12-15
Sec. 0.5.
The following definitions apply throughout this rule:
(1) "Tobacco dependence treatment" means the provision of products and services intended to reduce a person's dependence on tobacco products. The term includes the provision of the following: (A) Covered legend or nonlegend drugs intended to reduce an individual's dependence on tobacco products.(B) Tobacco dependence counseling services offered in conjunction with the delivery of a drug defined in clause (A) or by an individual identified under section 3 of this rule.(2) "Tobacco products" means, but is not limited to, the following:(D) Inhaled tobacco products.(E) Ingestible tobacco products.Filed 5/27/2016, 12:05 p.m.: 20160622-IR-405140338FRAReadopted filed 7/28/2022, 2:21 p.m.: 20220824-IR-405220205RFAReadopted filed 5/30/2023, 11:54 a.m.: 20230628-IR-405230292RFA